← Back to Search

Behavioral Activation for Anhedonia

N/A
Waitlist Available
Led By Christian A Webb, Ph.D.
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-treatment (baseline) to post-treatment (12 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test a therapy called Behavioral Activation (BA) on adolescents who have trouble feeling pleasure due to depression. BA helps by encouraging them to do more activities they enjoy, which can improve their mood. The study will see how well this therapy works and what changes occur in the brain and behavior. Behavioral Activation (BA) is a well-established treatment for depression that focuses on increasing engagement in enjoyable and meaningful activities to improve mood.

Eligible Conditions
  • Anhedonia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-treatment (baseline) to post-treatment (12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from pre-treatment (baseline) to post-treatment (12 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Anhedonic (Snaith-Hamilton Pleasure Scale; SHAPS) Symptoms
Change in Brain (Striatal and Medial PFC) Activation During a Monetary Reward Gambling Task
Change in Performance (Reward Learning) on the Probabilistic Reward Task (PRT) Computer Task

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Anhedonic teens receiving Behavioral Activation (BA)Experimental Treatment1 Intervention
12 weeks (1 50-min session per week) of Behavioral Activation for the anhedonic adolescents. Behavioral Activation is a psychosocial treatment for depression focused on gradually re-engaging patients with sources of reinforcement and reward in their environment (e.g., increasing activites and interpersonal interactions). In contrast to Cognitive Behavioral Therapy, and as the name implies, Behavioral Activation focuses on behavioral strategies to improve mood and places little emphasis on cognitive restructuring techniques.
Group II: Non-anhedonic teens (not receiving BA)Active Control1 Intervention
A group of adolescents with no anhedonia were recruited
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation
2013
Completed Phase 3
~2900

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,928 Previous Clinical Trials
2,744,939 Total Patients Enrolled
20 Trials studying Anhedonia
1,922 Patients Enrolled for Anhedonia
Mclean HospitalLead Sponsor
216 Previous Clinical Trials
21,793 Total Patients Enrolled
5 Trials studying Anhedonia
743 Patients Enrolled for Anhedonia
Christian A Webb, Ph.D.Principal InvestigatorMcLean Hospital & McLean Hospital

Media Library

Behavioral Activation Clinical Trial Eligibility Overview. Trial Name: NCT02498925 — N/A
~8 spots leftby Dec 2025